Intratumoral metabolic Hhterogeneity for prediction of disease progression after concurrent chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer. > Paper

Skip to content

Publications

Sub Visual

Paper

2014 Intratumoral metabolic Hhterogeneity for prediction of disease progres…

Post author info

profile_image
  • Author
  • Date 17-12-19 08:59
  • Views 0
  • Comments 0

Post content

Basic info

Basic info
Paper Intratumoral metabolic Hhterogeneity for prediction of disease progression after concurrent chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer.
Journal Nucl Med Mol Imaging
Author Kang SR, Song HC, Byun BH, Oh JR, Kim HS, Hong SP, Kwon SY, Chong A, Kim J, Cho SG, Park HJ, Kim YC, Ahn SJ, Min JJ, Bom HS.
Volume, Page 48(1):16-25.
Intratumoral metabolic Hhterogeneity for prediction of disease progression after concurrent chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer.